Patents by Inventor Yangyang Wang

Yangyang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200161353
    Abstract: An image sensor comprising a substrate, a black pixel area formed in the substrate including a black pixel radiation sensing element. an active pixel area formed in the substrate, and a buffer area, wherein the black pixel area and the active pixel area sandwich the buffer area in a transverse direction of the substrate, and a first blocking wall that at least partially blocks the radiation propagating towards the black pixel radiation sensing element via the buffer area in the substrate is formed in the buffer area.
    Type: Application
    Filed: September 13, 2019
    Publication date: May 21, 2020
    Applicant: HUAIAN IMAGING DEVICE MANUFACTURER CORPORATION
    Inventors: Yangyang WANG, Maoliang TANG, Shaodong LIU
  • Patent number: 10562721
    Abstract: The present disclosure provides a feeder and a backlight production apparatus. The feeder includes: a storing assembly configured to store a material tray on which a plurality of elements to be fed are placed; a fetching assembly configured to obtain the material tray from the storing assembly by sucking and transport the material tray; a distributing assembly configured to obtain at least one element to be fed by sucking from the material tray transported by the fetching assembly, and distribute the at least one element to be fed; and a turn-over assembly configured to turn over the at least one element to be fed distributed by the distributing assembly, and transport the at least one element to be fed to a next process unit.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: February 18, 2020
    Assignee: BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Jiabin Xie, Yangyang Wang, Zailin Hong, Xiaoguang Hong
  • Patent number: 10371544
    Abstract: A device and system for aiding in navigation. The system includes a vibrating haptic device, including a printed circuit board configured to determine a geographic position of a user, a battery, one or more isolation pads, and a plurality of actuators, and a mobile electronic device coupled to the vibrating haptic device, wherein the mobile electronic device is configured to analyze data gathered by the vibrating haptic device and determine a geographic position and angle of a user.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: August 6, 2019
    Assignee: WEARWORKS
    Inventors: Kevin Yoo, Keith Kirkland, Yangyang Wang
  • Publication number: 20190092589
    Abstract: The present disclosure provides a feeder and a backlight production apparatus. The feeder includes: a storing assembly configured to store a material tray on which a plurality of elements to be fed are placed; a fetching assembly configured to obtain the material tray from the storing assembly by sucking and transport the material tray; a distributing assembly configured to obtain at least one element to be fed by sucking from the material tray transported by the fetching assembly, and distribute the at least one element to be fed; and a turn-over assembly configured to turn over the at least one element to be fed distributed by the distributing assembly, and transport the at least one element to be fed to a next process unit.
    Type: Application
    Filed: March 22, 2018
    Publication date: March 28, 2019
    Inventors: Jiabin XIE, Yangyang WANG, Zailin HONG, Xiaoguang HONG
  • Patent number: 10220091
    Abstract: Methods for treating cancer using a combination of an inhibitor of the sonic hedgehog signaling pathway (e.g., LDE225) with radiation and a tumor antigen-specific monoclonal antibody (e.g., heat shock protein (HSP) glucose regulated protein of 94000 daltons (Grp94)-specific mAb W9, or chondroitin sulfate proteoglycan 4 (CSPG4)-targeted mAbs), or with a BRAF inhibitor, e.g., in BRAF inhibitor resistant cancers.
    Type: Grant
    Filed: April 3, 2014
    Date of Patent: March 5, 2019
    Assignee: The General Hospital Corporation
    Inventors: Francesco Sabbatino, Yangyang Wang, Xinhui Wang, Steven Isakoff, Cristina Ferrone, Joe Schwab, Soldano Ferrone
  • Publication number: 20180321056
    Abstract: A device and system for aiding in navigation. The system includes a vibrating haptic device, including a printed circuit board configured to determine a geographic position of a user, a battery, one or more isolation pads, and a plurality of actuators, and a mobile electronic device coupled to the vibrating haptic device, wherein the mobile electronic device is configured to analyze data gathered by the vibrating haptic device and determine a geographic position and angle of a user.
    Type: Application
    Filed: November 8, 2017
    Publication date: November 8, 2018
    Inventors: Kevin YOO, Keith Kirkland, Yangyang Wang
  • Patent number: 9296811
    Abstract: Combinations of agents that have a synergistic effect for the treatment of a tumor are disclosed herein. These combinations of agents can be used to treat tumors, wherein the cells of the cancer express a mutated BRAF. Methods are disclosed for treating a subject diagnosed with a tumor that expresses a mutated BRAF. The methods include administering to the subject (1) a therapeutically effective amount of an antibody or antigen binding fragment thereof that specifically binds high molecular weight melanoma associated antigen (HMW-MAA), also known as CSPG4; and (2) a therapeutically effective amount of a BRAF inhibitor. In some embodiments, the tumor is melanoma. In some embodiments the method includes selecting a subject with primary or secondary resistance to a BRAF inhibitor. In further embodiments, treating the tumor comprises decreasing the metastasis of the tumor. In additional embodiments, the BRAF inhibitor comprises PLX4032 or PLX4720.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: March 29, 2016
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Soldano Ferrone, Xinhui Wang, Elvira Favoino, Ling Yu, Yangyang Wang
  • Publication number: 20160045598
    Abstract: Methods for treating cancer using a combination of an inhibitor of the sonic hedgehog signaling pathway (e.g., LDE225) with radiation and a tumor antigen-specific monoclonal antibody (e.g., heat shock protein (HSP) glucose regulated protein of 94000 daltons (Grp94)-specific mAb W9, or chondroitin sulfate proteoglycan 4 (CSPG4)-targeted mAbs), or with a BRAF inhibitor, e.g., in BRAF inhibitor resistant cancers.
    Type: Application
    Filed: April 3, 2014
    Publication date: February 18, 2016
    Inventors: Francesco Sabbatino, Yangyang Wang, Xinhui Wang, Steven Isakoff, Cristina Ferrone, Joe Schwab, Soldano Ferrone
  • Publication number: 20140234324
    Abstract: Combinations of agents that have a synergistic effect for the treatment of a tumor are disclosed herein. These combinations of agents can be used to treat tumors, wherein the cells of the cancer express a mutated BRAF. Methods are disclosed for treating a subject diagnosed with a tumor that expresses a mutated BRAF. The methods include administering to the subject (1) a therapeutically effective amount of an antibody or antigen binding fragment thereof that specifically binds glucose regulated protein (GRP) 94; and (2) a therapeutically effective amount of a BRAF inhibitor. In some embodiments, the tumor is melanoma. In some embodiments the method includes selecting a subject with primary or secondary resistance to a BRAF inhibitor. In further embodiments, treating the tumor comprises decreasing the metastasis of the tumor. In additional embodiments, the BRAF inhibitor comprises PLX4032 or PLX4720.
    Type: Application
    Filed: May 2, 2014
    Publication date: August 21, 2014
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Soldano Ferrone, Xinhui Wang, Elvira Favoino, Ling Yu, Yangyang Wang
  • Patent number: 8771687
    Abstract: Combinations of agents that have a synergistic effect for the treatment of a tumor are disclosed herein. These combinations of agents can be used to treat tumors, wherein the cells of the cancer express a mutated BRAF. Methods are disclosed for treating a subject diagnosed with a tumor that expresses a mutated BRAF. The methods include administering to the subject (1) a therapeutically effective amount of an antibody or antigen binding fragment thereof that specifically binds glucose regulated protein (GRP) 94; and (2) a therapeutically effective amount of a BRAF inhibitor. In some embodiments, the tumor is melanoma. In some embodiments the method includes selecting a subject with primary or secondary resistance to a BRAF inhibitor. In further embodiments, treating the tumor comprises decreasing the metastasis of the tumor. In additional embodiments, the BRAF inhibitor comprises PLX4032 or PLX4720.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: July 8, 2014
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Soldano Ferrone, Xinhui Wang, Elvira Favoino, Ling Yu, Yangyang Wang
  • Publication number: 20130259873
    Abstract: Combinations of agents that have a synergistic effect for the treatment of a tumor are disclosed herein. These combinations of agents can be used to treat tumors, wherein the cells of the cancer express a mutated BRAF. Methods are disclosed for treating a subject diagnosed with a tumor that expresses a mutated BRAF. The methods include administering to the subject (1) a therapeutically effective amount of an antibody or antigen binding fragment thereof that specifically binds high molecular weight melanoma associated antigen (HMW-MAA), also known as CSPG4; and (2) a therapeutically effective amount of a BRAF inhibitor. In some embodiments, the tumor is melanoma. In some embodiments the method includes selecting a subject with primary or secondary resistance to a BRAF inhibitor. In further embodiments, treating the tumor comprises decreasing the metastasis of the tumor. In additional embodiments, the BRAF inhibitor comprises PLX4032 or PLX4720.
    Type: Application
    Filed: December 1, 2011
    Publication date: October 3, 2013
    Inventors: Soldano Ferrone, Xinhui Wang, Elvira Favoino, Ling Yu, Yangyang Wang
  • Publication number: 20120148598
    Abstract: Combinations of agents that have a synergistic effect for the treatment of a tumor are disclosed herein. These combinations of agents can be used to treat tumors, wherein the cells of the cancer express a mutated BRAF. Methods are disclosed for treating a subject diagnosed with a tumor that expresses a mutated BRAF. The methods include administering to the subject (1) a therapeutically effective amount of an antibody or antigen binding fragment thereof that specifically binds glucose regulated protein (GRP) 94; and (2) a therapeutically effective amount of a BRAF inhibitor. In some embodiments, the tumor is melanoma. In some embodiments the method includes selecting a subject with primary or secondary resistance to a BRAF inhibitor. In further embodiments, treating the tumor comprises decreasing the metastasis of the tumor. In additional embodiments, the BRAF inhibitor comprises PLX4032 or PLX4720.
    Type: Application
    Filed: December 1, 2011
    Publication date: June 14, 2012
    Inventors: Soldano Ferrone, Xinhui Wang, Elvira Favoino, Ling Yu, Yangyang Wang